$Vertex Pharmaceuticals (VRTX.US)$ & $CRISPR Therapeutics (C...
$Vertex Pharmaceuticals(VRTX.US$ & $CRISPR Therapeutics(CRSP.US$
📣 Announces CASGEVY™ (exagamglogene autotemcel) FDA approval on 01/16🥳
📣 Announces CASGEVY™ (exagamglogene autotemcel) FDA approval on 01/16🥳
⇒ Treatment of transfusion-dependent beta-thalassemia (TDT) in patients 12 yrs and older👏
⇒ One-time treatment⭐
ℹ️ Drug info:
• CASGEVY™ (exagamglogene autotemcel [exa-cel])
• CASGEVY™ (exagamglogene autotemcel [exa-cel])
⇒ PDUFA goal date: 3/30/24
⇒ BLA
⇒ Transfusion-dependent beta-thalassemia (TDT)
⇒ CRISPR/Cas9 gene-edited cell therapy
⇒ BLA
⇒ Transfusion-dependent beta-thalassemia (TDT)
⇒ CRISPR/Cas9 gene-edited cell therapy
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
